Literature DB >> 22591743

Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.

Yi Xiao1, F Peter Guengerich.   

Abstract

Human cytochrome P450 (P450) 2W1 is still considered an "orphan" because its physiological function is not characterized. To identify its substrate specificity, the purified recombinant enzyme was incubated with colorectal cancer extracts for untargeted substrate searches using an LC/MS-based metabolomic and isotopic labeling approach. In addition to previously reported fatty acids, oleyl (18:1) lysophosphatidylcholine (LPC, lysolecithin) was identified as a substrate for P450 2W1. Other human P450 enzymes tested showed little activity with 18:1 LPC. In addition to the LPCs, P450 2W1 acted on a series of other lysophospholipids, including lysophosphatidylinositol, lysophosphatidylserine, lysophosphatidylglycerol, lysophosphatidylethanolamine, and lysophosphatidic acid but not diacylphospholipids. P450 2W1 utilized sn-1 18:1 LPC as a substrate much more efficiently than the sn-2 isomer; we conclude that the sn-1 isomers of lysophospholipids are preferred substrates. Chiral analysis was performed on the 18:1 epoxidation products and showed enantio-selectivity for formation of (9R,10S) over (9S,10R). [corrected]. The kinetics and position specificities of P450 2W1-catalyzed oxygenation of lysophospholipids (16:0 LPC and 18:1 LPC) and fatty acids (C16:0 and C18:1) were also determined. Epoxidation and hydroxylation of 18:1 LPC are considerably more efficient than for the C18:1 free fatty acid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591743      PMCID: PMC3540858          DOI: 10.1194/jlr.M027185

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

2.  Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes.

Authors:  Raymundo Sanchez-Ponce; F Peter Guengerich
Journal:  Anal Chem       Date:  2007-04-05       Impact factor: 6.986

3.  Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

Authors:  Maria Karlgren; Alvin Gomez; Katarina Stark; Jenny Svärd; Cristina Rodriguez-Antona; Ernst Oliw; Maria Luisa Bernal; Santiago Ramón y Cajal; Inger Johansson; Magnus Ingelman-Sundberg
Journal:  Biochem Biophys Res Commun       Date:  2006-01-11       Impact factor: 3.575

4.  Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.

Authors:  Huanchun Zhang; Agnieszka Bialkowska; Raluca Rusovici; Sengthong Chanchevalap; Hyunsuk Shim; Jonathan P Katz; Vincent W Yang; C Chris Yun
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

5.  Assignment of endogenous substrates to enzymes by global metabolite profiling.

Authors:  Alan Saghatelian; Sunia A Trauger; Elizabeth J Want; Edward G Hawkins; Gary Siuzdak; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2004-11-16       Impact factor: 3.162

6.  Enzymatic properties of human CYP2W1 expressed in Escherichia coli.

Authors:  Hidenori Yoshioka; Noriyuki Kasai; Shinichi Ikushiro; Raku Shinkyo; Masaki Kamakura; Miho Ohta; Kuniyo Inouye; Toshiyuki Sakaki
Journal:  Biochem Biophys Res Commun       Date:  2006-04-27       Impact factor: 3.575

7.  Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry.

Authors:  Junko Adachi; Migiwa Asano; Naoki Yoshioka; Hideyuki Nushida; Yasuhiro Ueno
Journal:  Kobe J Med Sci       Date:  2006

8.  Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A.

Authors:  Li V Yang; Caius G Radu; Li Wang; Mireille Riedinger; Owen N Witte
Journal:  Blood       Date:  2004-09-21       Impact factor: 22.113

9.  Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.

Authors:  Zhong-Liu Wu; Christal D Sohl; Tsutomu Shimada; F Peter Guengerich
Journal:  Mol Pharmacol       Date:  2006-03-21       Impact factor: 4.436

10.  Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.

Authors:  Zhenwen Zhao; Yijin Xiao; Paul Elson; Haiyan Tan; Sarah J Plummer; Michael Berk; Phyu P Aung; Ian C Lavery; Jean P Achkar; Li Li; Graham Casey; Yan Xu
Journal:  J Clin Oncol       Date:  2007-07-01       Impact factor: 44.544

View more
  13 in total

1.  Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1.

Authors:  Michal Siller; Sandeep Goyal; Francis K Yoshimoto; Yi Xiao; Shouzou Wei; F Peter Guengerich
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

2.  Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms.

Authors:  Xin Gao; Hengyan Qu; Chun-Zhi Ai; Yun-Feng Cao; Ting Huang; Jian-Xing Chen; Jia Zeng; Xiao-Yu Sun; Mo Hong; Frank J Gonzalez; Zeyuan Liu; Zhong-Ze Fang
Journal:  Xenobiotica       Date:  2014-09-26       Impact factor: 1.908

3.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.

Authors:  Valerian E Kagan; Gaowei Mao; Feng Qu; Jose Pedro Friedmann Angeli; Sebastian Doll; Claudette St Croix; Haider Hussain Dar; Bing Liu; Vladimir A Tyurin; Vladimir B Ritov; Alexandr A Kapralov; Andrew A Amoscato; Jianfei Jiang; Tamil Anthonymuthu; Dariush Mohammadyani; Qin Yang; Bettina Proneth; Judith Klein-Seetharaman; Simon Watkins; Ivet Bahar; Joel Greenberger; Rama K Mallampalli; Brent R Stockwell; Yulia Y Tyurina; Marcus Conrad; Hülya Bayır
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

4.  A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Authors:  Mostafa I Fekry; Yi Xiao; Jeannette Zinggeler Berg; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-09-11       Impact factor: 3.922

Review 5.  Activity-based annotation: the emergence of systems biochemistry.

Authors:  Kyu Y Rhee; Robert S Jansen; Christoph Grundner
Journal:  Trends Biochem Sci       Date:  2022-04-13       Impact factor: 14.264

6.  Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates.

Authors:  Yan Zhao; Debin Wan; Jun Yang; Bruce D Hammock; Paul R Ortiz de Montellano
Journal:  Drug Metab Dispos       Date:  2016-03-02       Impact factor: 3.922

7.  Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.

Authors:  Aaron G Bart; Goreti Morais; Venu R Vangala; Paul M Loadman; Klaus Pors; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2021-10-04       Impact factor: 3.922

8.  Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors.

Authors:  Eva Choong; Jia Guo; Anna Persson; Susanne Virding; Inger Johansson; Souren Mkrtchian; Magnus Ingelman-Sundberg
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

9.  CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.

Authors:  Cristina L Ronchi; Silviu Sbiera; Marco Volante; Sonja Steinhauer; Vanessa Scott-Wild; Barbara Altieri; Matthias Kroiss; Margarita Bala; Mauro Papotti; Timo Deutschbein; Massimo Terzolo; Martin Fassnacht; Bruno Allolio
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

10.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.